Bone scanning in lung cancer: Pretest probability is of value

Por Puglisi, Fabio
Publicado em 2004

Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report

Por Fasola, Gianpiero, Puglisi, Fabio, Follador, Alessandro, Aita, Marianna, Di Terlizzi, Silvia, Belvedere, Ornella
Publicado em 2006

Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients

Por Aprile, Giuseppe, Lutrino, Stefania Eufemia, Ferrari, Laura, Casagrande, Mariaelena, Bonotto, Marta, Ongaro, Elena, Puglisi, Fabio
Publicado em 2013

Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?

Por Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Minisini, Alessandro Marco, Rihawi, Karim, Fasola, Gianpiero, Puglisi, Fabio
Publicado no Oncologist (2015)

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example

Por Gerratana, Lorenzo, De Maglio, Giovanna, De Pellegrin, Alessandro, Follador, Alessandro, Rihawi, Karim, Pizzolitto, Stefano, Puglisi, Fabio, Fasola, Gianpiero
Publicado no Onco Targets Ther (2016)

HEX expression and localization in normal mammary gland and breast carcinoma

Por Puppin, Cinzia, Puglisi, Fabio, Pellizzari, Lucia, Manfioletti, Guidalberto, Pestrin, Marta, Pandolfi, Maura, Piga, Andrea, Di Loreto, Carla, Damante, Giuseppe
Publicado em 2006

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients’ heart?

Por Fontanella, Caterina, Aita, Marianna, Cinausero, Marika, Aprile, Giuseppe, Baldin, Maria Grazia, Dusi, Veronica, Lestuzzi, Chiara, Fasola, Gianpiero, Puglisi, Fabio
Publicado em 2014

Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario

Por Bonotto, Marta, Gerratana, Lorenzo, Poletto, Elena, Driol, Pamela, Giangreco, Manuela, Russo, Stefania, Minisini, Alessandro M., Andreetta, Claudia, Mansutti, Mauro, Pisa, Federica E., Fasola, Gianpiero, Puglisi, Fabio
Publicado em 2014

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Por Russillo Michelangelo, Nisticò Cecilia, Milella Michele, Carlini Paolo, Sperduti Isabella, Fabi Alessandra, Puglisi Fabio, Vaccaro Vanja, Bria Emilio, Cuppone Federica, Papaldo Paola, Ferretti Gianluigi, Aapro Matti, Giannarelli Diana, Cognetti Francesco
Publicado em 2011-05-01

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Por Cuppone, Federica, Bria, Emilio, Vaccaro, Vanja, Puglisi, Fabio, Fabi, Alessandra, Sperduti, Isabella, Carlini, Paolo, Milella, Michele, Nisticò, Cecilia, Russillo, Michelangelo, Papaldo, Paola, Ferretti, Gianluigi, Aapro, Matti, Giannarelli, Diana, Cognetti, Francesco
Publicado em 2011

In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis

Por Bulfoni, Michela, Gerratana, Lorenzo, Del Ben, Fabio, Marzinotto, Stefania, Sorrentino, Marisa, Turetta, Matteo, Scoles, Giacinto, Toffoletto, Barbara, Isola, Miriam, Beltrami, Carlo Alberto, Di Loreto, Carla, Beltrami, Antonio Paolo, Puglisi, Fabio, Cesselli, Daniela
Publicado no Breast Cancer Res (2016)

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress

Por Cesaratto, Laura, Grisard, Eleonora, Coan, Michela, Zandonà, Luigi, De Mattia, Elena, Poletto, Elena, Cecchin, Erika, Puglisi, Fabio, Canzonieri, Vincenzo, Mucignat, Maria Teresa, Zucchetto, Antonella, Stocco, Gabriele, Colombatti, Alfonso, Nicoloso, Milena S, Spizzo, Riccardo
Publicado no Cell Death Dis (2016)

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress

Por Cesaratto, Laura, Grisard, Eleonora, Coan, Michela, Zandonà, Luigi, De Mattia, Elena, Poletto, Elena, Cecchin, Erika, Puglisi, Fabio, Canzonieri, Vincenzo, Mucignat, Maria Teresa, Zucchetto, Antonella, Stocco, Gabriele, Colombatti, Alfonso, Nicoloso, Milena S, Spizzo, Riccardo
Publicado no Cell Death Dis (2016)

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients

Por Lambertini, Matteo, Pinto, Ana Catarina, Ameye, Lieveke, Jongen, Lynn, Del Mastro, Lucia, Puglisi, Fabio, Poggio, Francesca, Bonotto, Marta, Floris, Giuseppe, Van Asten, Kathleen, Wildiers, Hans, Neven, Patrick, de Azambuja, Evandro, Paesmans, Marianne, Azim Jr, Hatem A
Publicado no Br J Cancer (2016)

Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Ital...

Por Lambertini, Matteo, Ferreira, Arlindo R., Poggio, Francesca, Puglisi, Fabio, Bernardo, Antonio, Montemurro, Filippo, Poletto, Elena, Pozzi, Emma, Rossi, Valentina, Risi, Emanuela, Lai, Antonella, Zanardi, Elisa, Sini, Valentina, Ziliani, Serena, Minuti, Gabriele, Mura, Silvia, Grasso, Donatella, Fontana, Andrea, Del Mastro, Lucia
Publicado no Oncologist (2015)

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: the CASA randomized...

Por Crivellari, Diana, Gray, Kathryn P, Dellapasqua, Silvia, Puglisi, Fabio, Ribi, Karin, Price, Karen N, Láng, István, Gianni, Lorenzo, Spazzapan, Simon, Pinotti, Graziella, Lüthi, Jean-Marc, Gelber, Richard D, Regan, Meredith M, Colleoni, Marco, Castiglione-Gertsch, Monica, Maibach, Rudolf, Rabaglio, Manuela, Coates, Alan S, Goldhirsch, Aron
Publicado em 2013

Adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression: patient-reported outcomes in the TEXT and SOFT randomised trial...

Por Bernhard, Jürg, Luo, Weixiu, Ribi, Karin, Colleoni, Marco, Burstein, Harold J., Tondini, Carlo, Pinotti, Graziella, Spazzapan, Simon, Ruhstaller, Thomas, Puglisi, Fabio, Pavesi, Lorenzo, Parmar, Vani, Regan, Meredith M., Pagani, Olivia, Fleming, Gini F., Francis, Prudence A., Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Walley, Barbara A.
Publicado no Lancet Oncol (2015)

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

Por Colleoni, Marco, Gray, Kathryn P., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio, Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Viale, Giuseppe, Goldhirsch, Aron
Publicado no J Clin Oncol (2016)

Adjuvant ovarian function suppression and cognitive function in women with breast cancer

Por Phillips, Kelly-Anne, Regan, Meredith M, Ribi, Karin, Francis, Prudence A, Puglisi, Fabio, Bellet, Meritxell, Spazzapan, Simon, Karlsson, Per, Budman, Daniel R, Zaman, Khalil, Abdi, Ehtesham A, Domchek, Susan M, Feng, Yang, Price, Karen N, Coates, Alan S, Gelber, Richard D, Maruff, Paul, Boyle, Frances, Forbes, John F, Ahles, Tim, Fleming, Gini F, Bernhard, Jürg
Publicado no Br J Cancer (2016)

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian...

Por Ribi, Karin, Luo, Weixiu, Bernhard, Jürg, Francis, Prudence A., Burstein, Harold J., Ciruelos, Eva, Bellet, Meritxell, Pavesi, Lorenzo, Lluch, Ana, Visini, Marilena, Parmar, Vani, Tondini, Carlo, Kerbrat, Pierre, Perelló, Antonia, Neven, Patrick, Torres, Roberto, Lombardi, Davide, Puglisi, Fabio, Karlsson, Per, Ruhstaller, Thomas, Colleoni, Marco, Coates, Alan S., Goldhirsch, Aron, Price, Karen N., Gelber, Richard D., Regan, Meredith M., Fleming, Gini F.
Publicado no J Clin Oncol (2016)